Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 |
| Revenues | 45.5 | 36.0 | 27.3 | 43.5 | 32.6 |
| Revenue growth | 26.5% | 31.7% | -37.2% | 33.6% | |
| Cost of goods sold | 24.9 | 17.6 | 16.7 | 16.0 | 8.2 |
| Gross profit | 20.6 | 18.4 | 10.6 | 27.5 | 24.4 |
| Gross margin | 45.4% | 51.1% | 38.7% | 63.2% | 74.8% |
| Selling, general and administrative | 21.0 | 15.6 | 14.8 | 14.8 | 7.4 |
| EBIT | -14.3 | -6.9 | -13.0 | 4.0 | 10.3 |
| EBIT margin | -31.5% | -19.2% | -47.5% | 9.3% | 31.8% |
| Pre-tax income | -20.2 | -11.4 | -17.2 | -0.4 | 8.4 |
| Income taxes | 0.1 | 0.0 | 0.0 | 0.0 | 0.1 |
| Tax rate | | | | 8.6% | 0.9% |
| Net income | -20.3 | -11.4 | -17.3 | -0.4 | 8.3 |
| Net margin | -44.5% | -31.7% | -63.3% | -1.0% | 25.6% |
| |
| Diluted EPS | ($0.36) | ($0.36) | ($0.78) | ($0.02) | $0.46 |
| Shares outstanding (diluted) | 56.3 | 31.6 | 22.1 | 21.5 | 18.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|